Medpace Holdings CEO August Troendle sells $44.4m stock
August J. Troendle, CEO of Medpace Holdings Inc., sold a substantial amount of the company's stock in September 2026. In two separate transactions, he sold 70,901 shares, valued at roughly $44.4 million. The share price ranged between $620.00 and $632.815 at the time of sale. Despite this insider sale, Medpace Holdings has been actively buying back shares.
The company reported strong second-quarter 2026 results, exceeding Wall Street's expectations with increased revenue and earnings per share. Following these sales, Mr. Troendle still holds over 400,000 shares of Medpace Holdings, including indirect ownership through his LLC. The company's management remains optimistic about its future performance.
Written by urgent.news from Investing.com's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
This story
This is one outlet's version. Read the fullest account.
